Trump’s Tariffs Set to Hit Ireland’s Pharmaceutical Exports
Drugmakers face new economic challenges as tariffs take effect
New tariffs imposed by the Trump administration are set to strike Ireland’s pharmaceutical exports, a sector that has long benefited from favorable tax structures.
The move is expected to disrupt supply chains and raise costs for drugmakers that rely heavily on the Irish market for production.
The move is expected to disrupt supply chains and raise costs for drugmakers that rely heavily on the Irish market for production.
